CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Maria Guardiola-Ripoll - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Maria Guardiola-Ripoll

Sara Borrell Research Fellow at Institut de Recerca Biomèdica Catalunya Sud (IRBCatSud) within the Genetics and Environment in Psychiatry (GEP) research group. Interested in the genetic background underlying mental conditions and in the evolutionary changes that shaped our brain and made us vulnerable to neuropsychiatric disorders.

OPENALEX: A5103181311↗ORCID: 0000-0001-6949-5687↗

Affiliations

Organizations

Centre for Biomedical Network Research on Rare Diseasesauthorship · ES Centro de Investigación Biomédica en Red de Salud Mentalauthorship · ES Fidmag Sisters Hospitallersauthorship · ES Instituto de Investigación de Enfermedades Rarasauthorship · ES Instituto de Salud Carlos IIIauthorship · ES

Public evidence

3 connected articles

Clinical and cognitive outcomes in first-episode psychosis: focus on the interplay between cannabis use and genetic variability in endocannabinoid receptors.2024 · Europe PMC Genetic and Neurodevelopmental Markers in Schizophrenia-Spectrum Disorders: Analysis of the Combined Role of the <i>CNR1</i> Gene and Dermatoglyphics.2024 · Europe PMC Cannabis Use and Endocannabinoid Receptor Genes: A Pilot Study on Their Interaction on Brain Activity in First-Episode Psychosis.2023 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.